LATEST NEWS
- Behind the Science
Karen Barnes reflects on a career in science—from tracking elephants to supporting LJI research
- Research News
New study highlights VP40 as a promising therapeutic target
- Behind the Science
How Ian Mathews used Tullie and Rickey Families SPARK Awards funding to make cancer therapy advances and launch a career in medicine
- In the News
Reactions reflect unique features of an individual’s immune system, not the strength of a response
- In the News
Antibodies can change to counter new forms of the shape-shifting virus, research hints
- Behind the Science
San Diego artist Patricia Pauchnick on how she assembled her illustration for the Immune Matters magazine article "How Pandemics End"
- In the News
The rapid rise in different parts of the world of deadly, more infectious coronavirus variants that share new mutations is leading scientists to ask a critical question
- Research News
New LJI research could guide the development of more effective cancer immunotherapies
- Institute News
New funding will support high-risk, high-reward projects led by two early-career scientists
- Research News
Saliva-based COVID-19 screen proves fast, cheap and reliable
- Institute News
La Jolla, CA—Erica Ollmann Saphire, Ph.D., has been appointed President and CEO of La Jolla Institute for Immunology (LJI), the Institute announced today.
- Behind the Science
Testing for breast and ovarian cancers has come a long way—but at-risk patients still fall through the cracks. LJI scientist Anup Kumar Singh has won funding to learn more about cancer-causing mutations.
